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We have used circular dlchrolsm spectroscopy to confirm that. in a membrane-mlmlcking solvent. qBP( 140) adopts a partially helical conformation 
and we have demonstrated the loss of this structure m the presence of physiologically relevant concentrations of alumimum. This is the first evidence 
of a direct biochemical interaction between aluminium and ,&amylold and may have important Implications for the pathogenesls of ,4lzhelmer’s 
disease 
Aluminum (biology): P-Amylold protem: Alzheimer’s disease. Circular dichrolsm spectroscopy 
1. INTRODUCTION 
Controversy surrounds the involvement of both alu- 
minium and /3-amyloid in the aetiology of Alzheimer’s 
disease (AD). The cerebral deposition ofj$amyloid, and 
possibly aluminium, is an invariant feature of the dis- 
ease; however, a mechanism that adequately links the 
presence of either P-amyloid or aluminium to the neu- 
ronal degeneration that is characteristic of AD has not 
been described. Both aluminium [l] and P-amyloid [2] 
are neurotoxic and, in both. cell death is linked with 
disruptions in calcium homeostasis [3,4]. Recent evi- 
dence that qBP( l-40) forms transmembrane calcium 
channels in vitro that are irreversibly blocked by alu- 
minium [5] prompted us to investigate the effect of alu- 
minium on the conformation of this peptide. 
2. EXPERIMENTAL 
Synthetic A@P( 140) and qBP(25-35) were obtained from Bachem 
Inc (CA. USA) and solutions prepared as detailed below. @P(I40) 
peptide was dissolved m MdhQ water to give a nominal [peptide] of 
1.39 mmol~dm-’ The dissolved peptide was then diluted with 10 
mmol drn-’ Trls buffer, pH 7.0, to give a final stock solu- 
tion concentration of 0.23 mmol.dm-‘. Prior to use the stock was 
incubated at 37°C for 24 h as per the manufacturers Instruction. After 
incubation traces of msoluble material were removed by centrifuga- 
tlon. For circular dichrolsm (CD) analysis the peptlde was added to 
a solvent of 60% TFE (Aldrich, NMR Grade) /400/c 10 mmol ‘drn-’ 
Tris buffer at pH 7.0 to give a working [peptide] of 40 ~rnol~dm-’ 
Alummium was added from a 5 mmol dmm2 AI(NO,), 9H,O(Aldrlch) 
stock solution to give final nominal stock concentrations of 0. 10. 20. 
50. 100, 300, 250 and 300 pmol dm-‘. The ApP(35-35) peptide was 
lmmechately dissolved in a solvent of 60% TFE/40% Tris buffer at pH 
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7.0 to give a stock solution concentration of 0 23 mmol~dm-‘. The 
peptide was initially used at a final concentration of 40 ~rnol~dm~‘, 
however. because of the poor resolution of the spectra obtamed at 
this concentration subsequent spectra were run at a [peptlde] of 0 13 
mmol.dm~‘. Alummlum was added as per ApP( 140) to give final 
nominal concentrations of 0. 10. 20 and 50 ~rnol~drn~’ Concen- 
tratlons of the peptide stock solutions were verltied by measurements 
of tyrosme absorbance at 280 nm. 
CD spectra of both peptldes were recorded at 37°C on a JASCO 
J-600 spectropolarimeter usmg quartz cells of a 0 05 cm path length. 
3. RESULTS AND DISCUSSION 
The conformations, in a membrane-mimicking sol- 
vent, of the polypeptide fragments ApP( l-40) and 
ApP(25-35) were studied using CD spectroscopy. The 
spectrum obtained for ApP( l-40) (Fig. 1) was in close 
agreement with that reported for the similar ApP( 142) 
peptide [6]; that for the ApP(25-35) peptide (Fig. 2) has 
not hitherto been reported. Using the values of eZol( [7]. 
a-helical contents of 20% and 0% are obtained for 
Aj?P( 140) and qBP(25-35), respectively. We have also 
used the CONTIN method [8] to analyse the spectra. 
This gave values for the cl-helical content in close accord 
with the eZo8 analysis (21% and 5% for ApP( 140) and 
A/?P(25-35) respectively). The P-sheet contents were 
58% and 61% respectively, with the remainder (includ- 
ing/?-turn and random coil) 21% and 34%, respectively. 
Although the exact values of the P-sheet and remainder 
contents should be treated with a degree of caution, in 
view of the uncertainty regarding the application of 
reference spectra that are based on sets of globular pro- 
teins to the analysis of small peptides [9], the a-helical 
contents of the peptides can be regarded as reliable. It 
is of interest that the spectrum of the peptide ApP(29- 
42) (which overlaps with ApP(25-35)) has been anal- 
ysed in terms of a large P-sheet content (61%) [6] and 
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Fig 1, The effect of alummium on the CD spectrum of the A/IP( 140) polypeptlde Spectra for 10. 20 and 50 pumol. drn-’ alumimum were Identical 
to the pure peptlde. The spectrum for 100 pmol dm-’ alummlum IS not shoan. 
it has been suggested that this region of the polypeptide 
represents a possible nucleation site for acquisition of 
further p-sheet structure. 
Addition of aluminium (50 prnol.dm-‘) had a small 
but significant effect on the spectrum of ApP(25535). 
with the principal changes observed at wavelengths 
below 210 nm (Fig. 2). Analyses based on the values of 
13~“~ and on the CONTIN method indicated that the 
cl-helical content had not changed, although there ap- 
peared to be a minor redistribution between p-sheet and 
remainder contents. 
In marked contrast there was no detectable effect of 
this concentration of aluminium on the spectrum of 
Aj?P( 140) (Fig. 1). presumably reflecting the greater 
conformational stability of the longer peptide. Consis- 
tent with this, there was no change in the intensity of 
tyrosine fluorescence of the ApP( 140) peptide on addi- 
tion of 50 pmol .drnm3 aluminium. Additions of higher 
concentrations of aluminium had a dramatic effect on 
the c.d. spectrum of ApP( 140) (Fig. 1). the a-helical 
content of the peptide being all but abolished at an 
aluminium concentration of 300 pmol.dm-3 (Fig. 3). 
The effects of aluminium on the spectrum of this peptide 
were not uniform over the wavelength range and this 
may indicate that aluminium could cause a number of 
effects on the conformation by being bound at more 
than one site on the peptide. The increasing noise below 
200 nm in the presence of the higher concentrations of 
aluminium made application of the CONTIN proce- 
dure less reliable; in general terms the analysis indicated 
a decrease in the a-helical and P-sheet contents and an 
increase in the remainder. 
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Fig. 2. The effect of alummium on the CD spectrum of the A,BPf25-35) polypeptlde Spectra for IO and 20 firnol~dm~’ alummium were ldentlcal 
to the spectrum for the pure peptlde 
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Fig. 3. The abolition by alumimum of the a-helical content of the 
qBP(140) polypeptide. 
An in vivo association between aluminium and p- 
amyloid protein has been implied from various post- 
mortem analyses of the brains of AD sufferers [lo]. The 
results presented herein represent the first evidence of 
an in vitro interaction of physiologically relevant con- 
centrations of aluminium with the P-amyloid protein. 
The interactions are unique in terms of previous studies 
of aluminium and neuropeptides in that neurofilament 
phosphorylation [1 1] was not invoked as a prerequisite 
to an effect of aluminium. Our results support the recent 
demonstration that qBP(l-40) could act as a cation- 
selective transmembrane ion channel in vivo [5]. The 
blockade of this channel by aluminium might now be 
explained in terms of the capacity of aluminium to dis- 
rupt the a-helical conformation of the polypeptide. 
How the interaction of aluminium with the P-amyloid 
protein might contribute towards the pathogenesis of 
Alzheimer’s disease is not yet known. We have, how- 
ever, given one of the first strong indications that the 
respective roles of aluminium (at concentrations below 
the sensitivity threshold of nuclear microscopy [ 121) and 
/?-amyloid in the aetiology of Alzheimer’s disease may 
not be mutually exclusive. 
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